DISTINGUISHING BETWEEN CLOSED AND OPEN AIRWAY APNEAS AND TREATING PATIENTS ACCORDINGLY

• US 20110011402A1
• Filed: 09/29/2010
• Published: 01/20/2011
• Est. Priority Date: 11/05/1993
• Status: Active Grant

• Current Assignee: Resmed Limited (ResMed Incorporated)
• Original Assignee: Resmed Limited (ResMed Incorporated)
• Inventors: BERTHON-JONES, Michael
• Granted Patent: US 8,381,722 B2
• Time in Patent Office: Days
• US Class Current: 128/204.23
• CPC Class Codes: A61B 5/087 Measuring breath flow
• CPC Class Codes: A61B 5/7257 using Fourier transforms
• CPC Class Codes: A61F 5/56 Devices for preventing snoring by influencing the respiratory system by gas treatment A61M16/00
• CPC Class Codes: A61M 16/0006 with means for creating vibrations in patients' airways
• CPC Class Codes: A61M 16/0066 Blowers or centrifugal pumps
• CPC Class Codes: A61M 16/0069 the speed thereof being controlled by respiratory parameters, e.g. by inhalation
• CPC Class Codes: A61M 16/024 including calculation means, e.g. using a processor
• CPC Class Codes: A61M 16/06 Respiratory or anaesthetic masks
• CPC Class Codes: A61M 16/0875 Connecting tubes
• CPC Class Codes: A61M 2016/0039 in the inspiratory circuit
• CPC Class Codes: A61M 2230/60 Muscle strain, i.e. measured on the user

Abstract

Methods and apparatus for determining the occurrence of an apnea, patency and/or partial obstruction of the airway are disclosed. Respiratory air flow from a patient is measured to give an air flow signal. The determination of an apnea is performed by calculating the variance of the air flow signal over a moving time window and comparing the variance with a threshold value. One determination of partial obstruction of the airway is performed by detecting the inspiratory part of the air flow signal, scaling it to unity duration and area and calculating an index value of the amplitude of the scaled signal over a mid-portion. Alternatively, the index value is a measure of the flatness of the air flow signal over the mid-portion. One determination of patency of the airway is performed by applying an oscillatory pressure waveform of known frequency to a patient'"'"'s airway, calculating the magnitude of the component of said air flow signal at the known frequency induced by the oscillatory pressure waveform and comparing the calculated magnitude with a threshold value. Alternatively, the air flow signal is analysed to detect the presence of a component due to cardiogenic activity.

Claims

1-38. -38. (canceled)

39. Continuous positive airway pressure apparatus for treatment of respiratory conditions of a patient comprising:

means for determining a signal representative of patient respiratory flow;

a motor driven blower; and

a controller for detecting (i) flow limitations, (ii) apneas and (iii) hypopneas by operating on said signal indicative of patient respiratory flow; and

for controlling the motor driven blower to increase automatically a treatment pressure upon detection of at least one of flow limitation, apnea and hypopnea, and otherwise to automatically decrease the treatment pressure.

40. The apparatus of claim 39 wherein the controller detects an apnea by operating on the signal indicative of patient respiratory flow to recognize a reduction in ventilation below an apnea threshold.

41. The apparatus of claim 39 wherein the controller detects an hypopnea by operating on the signal indicative of patient respiratory flow to recognize a reduction in ventilation below an hypopnea threshold.

42. The apparatus of claim 39 wherein the controller further determines patency of the patient'"'"'s airway.

43. The apparatus of claim 42 wherein the controller controls the motor driven blower to increase automatically a treatment pressure upon determining that the airway is not patent, while leaving the treatment pressure unchanged or reduced upon determining that the airway is patent.

44. The apparatus of claim 39 wherein the controller further determines patency of the patient'"'"'s airway by detecting the presence of cardiogenic components in the signal indicative of patient respiratory flow.

45. The apparatus of claim 44 wherein the means for determining a signal representative of patient respiratory flow is at least one of a flow resistive element and differential pressure transducer, an ultrasonic flow transducer, and a pressure transducer.

46. The apparatus of claim 44 wherein the means for determining a signal representative of patient respiratory flow is a means for determining measurements of chest wall and/or abdominal movement.

47. The apparatus of claim 39 wherein the controller further determines patency of the patient'"'"'s airway by causing the motor driven blower to apply an oscillatory pressure waveform of known frequency to the patient'"'"'s airway, and operating on the signal indicative of patient respiratory flow to recognize a component at said known frequency induced by said oscillatory pressure waveform.

48. The apparatus of claim 47 wherein the means for determining a signal representative of patient respiratory flow is at least one of a flow resistive element and differential pressure transducer, an ultrasonic flow transducer, and a pressure transducer.

49. The apparatus of claim 47 wherein the means for determining a signal representative of patient respiratory flow is a means for determining measurements of chest wall and/or abdominal movement.

50. The apparatus of claim 39 wherein the means for determining a signal representative of patient respiratory flow is at least one of a flow resistive element and differential pressure transducer, an ultrasonic flow transducer, and a pressure transducer.

51. The apparatus of claim 39 wherein the means for determining a signal representative of patient respiratory flow is a means for determining measurements of chest wall and/or abdominal movement.